Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Plucknette

Surgery of the Hand Rochester, NY Medical Doctor

NPI 1790050425 CMS profile 1154697

30 Hagen Dr Ste 220, Ste 220, Rochester, NY 14625

Open in the dashboard

General payments

$122,624

142 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Plucknette of Rochester, NY is reported in the CMS Open Payments database as having received $122,624 across 142 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,983 30
2024 General $32,471 25
2023 General $20,186 16
2022 General $1,260 10
2021 General $12,370 18
2020 General $4,074 14
2019 General $8,280 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Plucknette
  • Surgery of the Hand median
  • Middle half of Surgery of the Hand
  • National median

In program year 2025, general payments to Benjamin Plucknette were reported at $43,983. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.

Show as a table
Year Benjamin Plucknette Surgery of the Hand median Middle half National median
2019 $8,280 $369 $108–$1,516 $163
2020 $4,074 $153 $56–$898 $114
2021 $12,370 $261 $84–$1,296 $132
2022 $1,260 $313 $103–$1,562 $149
2023 $20,186 $241 $95–$876 $160
2024 $32,471 $236 $84–$890 $164
2025 $43,983 $288 $115–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Skeletal Dynamics Inc $107,514 83 payments
  2. TriMed, Inc. $4,653 8 payments
  3. Medartis Inc. $3,180 1 payment
  4. Stryker Corporation $1,933 13 payments
  5. Medinc of Texas $722 2 payments
  6. AxoGen $648 5 payments
  7. Prodigy Surgical Distribution, Inc. $622 1 payment
  8. Anika Therapeutics, Inc. $569 2 payments
  9. Trice Medical, Inc. $432 5 payments
  10. Arthrex, Inc. $268 2 payments
  11. Other $2,084 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $82,277 12 payments
  2. Travel and Lodging $16,635 30 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,908 5 payments
  4. Food and Beverage $9,123 93 payments
  5. Honoraria $500 1 payment
  6. Long term medical supply or device loan $181 1 payment
Products named General payments · program years 2019–2025
  1. IMPlate $107,514 83 payments
  2. IJS $107,514 83 payments
  3. Geminus $107,514 83 payments
  4. Align $107,514 83 payments
  5. TOUCH $3,180 1 payment
  6. REUNION $1,386 6 payments
  7. WristMotion $471 1 payment
  8. AXOGUARD NERVE PROTECTOR $379 3 payments
  9. AxoGuard Nerve Connector $379 3 payments
  10. NA $225 2 payments
  11. Other $3,286 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

94

Median for Orthopedic Surgery: 203

Drug cost

$396

Median for Orthopedic Surgery: $1,433

Branded share of claims

30.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 27 $256
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 29 $76
Naproxen Generic 27 $49
Tramadol Hcl Generic 11 $15

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$15,397

Of which drugs: $23

Medicare patients

55

Average age 69

Services billed

401

31 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 60%
Diabetes 29%
Ischemic heart disease 25%
Depression 25%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 11 160 $14

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery of the Hand in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record